LEADER 04365nam 22006854a 450 001 9910824758803321 005 20230721005901.0 010 $a0-19-770627-4 010 $a0-19-970913-0 010 $a1-282-54365-2 010 $a9786612543654 010 $a0-19-974946-9 035 $a(CKB)2550000000010668 035 $a(EBL)3053635 035 $a(OCoLC)922969953 035 $a(SSID)ssj0000415825 035 $a(PQKBManifestationID)11264683 035 $a(PQKBTitleCode)TC0000415825 035 $a(PQKBWorkID)10420155 035 $a(PQKB)11457016 035 $a(Au-PeEL)EBL3053635 035 $a(CaPaEBR)ebr10375129 035 $a(CaONFJC)MIL254365 035 $a(Au-PeEL)EBL2012713 035 $a(OCoLC)958508988 035 $a(MiAaPQ)EBC3053635 035 $a(EXLCZ)992550000000010668 100 $a20070928d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe diagnosis and treatment of breakthrough pain$b[electronic resource] /$fPerry G. Fine ; with contributions by Andrew N. Davies, Scott M. Fishman 210 $aOxford ;$aNew York $cOxford University Press$d2008 215 $a1 online resource (139 p.) 225 1 $aOxford American pain library 300 $aDescription based upon print version of record. 311 $a0-19-536904-1 311 $a0-19-536903-3 320 $aIncludes bibliographical references and index. 327 $aIncidence, prevalence, and characteristics -- Clinical features -- Assessment -- Principles of management -- Oral opioid analgesics -- Oral transmucosal opioid analgesics -- Opioid analgesics via other routes -- Nonopioid pharmacotherapy -- Nonpharmacologic interventions -- Risk assessment and management in long-term opioid therapy. 330 $aBreakthrough pain (BTP) is episodic pain that emerges through the treatment of otherwise well-managed chronic background pain. Often called pain flare or transient pain, BTP negatively affects the function and quality of life of the patient and often results in a number of other physical, psychological and social problems. Breakthrough pain is a common occurrence affecting approximately two-thirds of the estimated 50 to 100 million chronic pain sufferers in the US. It can have multiple causes with various pathophysiologies, and can present with numerous clinical features and complications. The clinical features vary from individual to individual, and may vary within an individual over time. The successful management of breakthrough pain depends on proper assessment, treatment, and reassessment. Inadequate assessment can lead to ineffective or inappropriate treatment. Similarly, inadequate reassessment may lead to continuance of ineffective or even harmful treatment. In recent years, the need to educate physicians about pain management has been garnering increased attention from prominent medical associations and the media. Despite ongoing efforts to improve pain treatment, however, the need persists for evidence-based educational materials for physicians in the area of pain diagnosis and management. Part of the Oxford American Pain Library, this highly practical guide covers current approaches and new developments in the assessment and management of Breakthrough Pain, including both cancer-related pain and non-cancer chronic pain. It addresses the roles of opioid and non-opioid pharmacotherapy and presents non-pharmacologic interventions, as well. This concise yet comprehensive reference on Breakthrough Pain is ideal for palliative care doctors, anesthesiologists, pain medicine specialists and oncologists, as well as for primary care physicians 330 8 $aand internists on the frontlines of care. 410 0$aOxford American pain library. 606 $aPain$xDiagnosis$vHandbooks, manuals, etc 606 $aPain$xTreatment$vHandbooks, manuals, etc 615 0$aPain$xDiagnosis 615 0$aPain$xTreatment 676 $a616/.0472 700 $aFine$b P. G$g(Perry G.)$01190911 701 $aDavies$b Andrew$f1963-$01694212 701 $aFishman$b Scott$f1959-$01636644 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910824758803321 996 $aThe diagnosis and treatment of breakthrough pain$94114771 997 $aUNINA